XML 19 R40.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2020
Segment Reporting Information [Line Items]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Information regarding the Company’s segments for the three months ended March 31, 2020 and 2019 is as follows:
Revenues by segment
 
Three Months Ended
 
 
March 31,
(in thousands)
 
2020
 
2019
 
 
 
 
 
Medical Devices
 
$
5,985

 
$
6,726

Strategic Positions
 
—

 
—

Pharmaceutical
 
—

 
—

Income Generating Assets
 
10

 
(30
)
Total revenues
 
$
5,995

 
$
6,696

________________
The table above excludes revenues related to discontinued operations. See Note 2, Discontinued Operations Classified as Assets Held for Sale, for additional information.

(Loss) income by segment
 
Three Months Ended
 
 
March 31,
(in thousands)
 
2020
 
2019
 
 
 
 
 
Medical Devices
 
$
(2,111
)
 
$
(1,215
)
Strategic Positions
 
(10,900
)
 
—

Pharmaceutical (1)
 
(2,067
)
 
5,645

Income Generating Assets (1)
 
(16,645
)
 
2,250

Net (loss) income attributable to PDL’s shareholders
 
$
(31,723
)
 
$
6,680

________________
(1) The (Loss) income by segment presented above includes amounts related to both continuing and discontinued operations. See Note 2, Discontinued Operations Classified as Assets Held for Sale, for additional information.

Information regarding the Company’s segments as of March 31, 2020 and December 31, 2019 is as follows:
Long-lived assets by segment
 
 
 
 
(in thousands)
 
March 31,
2020
 
December 31,
2019
 
 
 
 
 
Medical Devices
 
$
3,172

 
$
2,435

Strategic Positions
 
—

 
—

Pharmaceutical (1)
 
2,908

 
2,960

Income Generating Assets
 
92

 
125

Total long-lived assets (1)
 
$
6,172

 
$
5,520